https://197lines.com/a-new-targeted-therapy-for-the-treatment-of-a-rare-bile-duct-cancer-called-cholangiocarcinoma-has-been-approved-by-the-therapeutic-goods-administration-a-decision-made-on-the-basis-of-overall-response-rate-and-duration-of-response